Universe Pharmaceuticals (UPC) has released an update.
Universe Pharmaceuticals has received a notification from Nasdaq regarding its non-compliance with the minimum bid price requirement, which mandates a share price of at least $1.00. The company has until April 2025 to rectify this issue and is considering options like a reverse stock split to meet the requirement. Despite this challenge, Universe Pharmaceuticals’ business operations remain unaffected.
For further insights into UPC stock, check out TipRanks’ Stock Analysis page.
